Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cerebral ischemia and inflammation.

C Iadecola1, M Alexander

  • 1Center for Clinical and Molecular Neurobiology, Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USA. iadec001@tc.umn.edu

Current Opinion in Neurology
|February 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between liver fibrosis and cognition in a nationally representative sample of older adults.

European journal of neurology·2020
Same author

Association between Intracranial Atherosclerotic Calcium Burden and Angiographic Luminal Stenosis Measurements.

AJNR. American journal of neuroradiology·2017
Same author

OC-02 - Risk of arterial thromboembolism in patients with breast cancer.

Thrombosis research·2016
Same author

Sex differences in NMDA GluN1 plasticity in rostral ventrolateral medulla neurons containing corticotropin-releasing factor type 1 receptor following slow-pressor angiotensin II hypertension.

Neuroscience·2015
Same author

The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction.

Nature communications·2014
Same author

Distribution of angiotensin type 1a receptor-containing cells in the brains of bacterial artificial chromosome transgenic mice.

Neuroscience·2012

Cerebral ischemia triggers inflammation, worsening brain damage. Targeting inflammation-related enzymes shows promise for reducing this damage in stroke patients.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathophysiology

Background:

  • Cerebral ischemia induces significant inflammation via cytokines and mediators.
  • Inflammation exacerbates brain damage in the late stages of ischemic stroke.

Purpose of the Study:

  • To evaluate the potential of anti-inflammatory therapies for treating late-stage cerebral ischemia.
  • To explore strategies targeting inflammation-related enzymes for neuroprotection.

Main Methods:

  • Review of preclinical and clinical studies on inflammatory responses in cerebral ischemia.
  • Analysis of therapeutic interventions targeting enzymes like inducible nitric oxide synthase and cyclo-oxygenase-2.

Main Results:

  • Preclinical data suggest that inhibiting inflammation reduces late-stage ischemic brain damage.

Related Experiment Videos

  • Blocking inducible nitric oxide synthase and cyclo-oxygenase-2 shows therapeutic potential with an extended window.
  • A prior clinical trial failure may be linked to immune responses to the therapeutic agent.

    • Conclusions:

    • There is a strong scientific rationale for pursuing anti-inflammatory therapies in cerebral ischemia.
    • Further research into targeting specific inflammatory pathways is warranted for stroke treatment.